Physician profile

James Counce

Fayetteville, AR

NPI 1104805498

$17,185.81

in general payments reported to CMS, 2019-2025

47 companies · $2,247 in 2025

The $2,247 reported for 2025 was more than what 94% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,666.53
Travel and Lodging$905.37
Education$91.64

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $6,418.62 2019-2024
Veran Medical Technologies, INC. $3,191.03 2019
Atricure, INC. $1,817.55 2019-2025 Epi-Sense Guided Coagulation System With Visitrax, Atricure Cryoice Cryosphere Cryoablation System
Abiomed $653.44 2020-2025
Abbott Laboratories $455.54 2020-2025 Epic, Coroflow
Medtronic, INC. $445.27 2021-2025 Avalus, Endurant Iis, Signia
Davol INC. $444.06 2023-2024 Progel Applicator Spray Tips, Arista Ah Flexitip
Astrazeneca Pharmaceuticals Lp $357.28 2020-2025 Imfinzi
Merck Sharp & Dohme LLC $273.33 2019-2025 Keytruda
Livanova USA, INC. $235.04 2022-2024 Essenz
Kls-Martin L.P. $215.33 2021
Novartis Pharmaceuticals Corporation $209.20 2019-2022
Amgen INC. $175.70 2019-2023 Lumakras
Takeda Pharmaceuticals U.S.A., INC. $158.37 2019-2025 Alunbrig, Fruzaqla
Elutia, INC. $157.47 2020-2021
Show all 47 companies
CompanyGeneral paymentsYearsTop products
Endologix LLC $146.19 2022
Janssen Pharmaceuticals, INC $139.00 2023-2024 Xarelto
Silk Road Medical, INC. $135.72 2021
Jazz Pharmaceuticals INC. $134.98 2021-2025 Zepzelca
Regeneron Healthcare Solutions, INC. $134.49 2022-2024 Libtayo
Stryker Corporation $125.06 2021-2023 Universal Neuro 3
Genentech USA, INC. $123.32 2021-2025 Tecentriq, Alecensa
Edwards Lifesciences Corporation $116.63 2021
Biom'Up Sa $112.73 2019
Boehringer Ingelheim Pharmaceuticals, INC. $103.10 2019-2022
Ethicon US, LLC $62.05 2021-2025 Evarrest
Daiichi Sankyo INC. $58.36 2024-2025 Enhertu
Blueprint Medicines Corporation $53.65 2020-2021
Janssen Biotech, INC. $49.41 2024-2025 Rybrevant
Becton, Dickinson and Company $46.33 2022
G1 Therapeutics, INC. $43.27 2022
Pharmacosmos Therapeutics INC. $41.82 2024-2025 Monoferric, Cosela
Genzyme Corporation $38.58 2022
Covidien Lp $37.71 2020
Biom'Up France Sas $35.91 2020
Lilly USA, LLC $34.18 2019-2021
Medtronic Vascular, INC. $32.85 2019
Nuvation Bio INC. $27.63 2025 Ibtrozi
Ethicon INC. $22.59 2020
Emd Serono, INC. $20.06 2025
Array Biopharma INC $19.94 2023 Xalkori, Lorbrena
Aveo Pharmaceuticals, INC. $15.53 2021
Pacira Pharmaceuticals Incorporated $15.28 2024 Exparel
Getinge USA Sales, LLC $14.04 2023 Flixene
Karyopharm Therapeutics INC. $12.94 2021
Bayer Healthcare Pharmaceuticals INC. $12.78 2019
Seagen INC. $12.45 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

James Counce

$17,185.81

in general payments reported 2019-2025

Years
2019-2025
Top company
Intuitive Surgical, INC.
Context
The $2,247 reported for 2025 was more than what 94% of providers received nationally.

https://glasscript.com/doctor/95009/james-counce

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.